Authors:
DUTTON PL
PAGE CC
CHEN X
RABANAL F
GIBNEY BR
SHARP RE
ISOGAI Y
VISSCHERS RW
PILLOUD D
REDDY KS
MULHOLLAND S
SHIFMAN J
GROSSET A
KALSBECK W
BOCIAN DF
SKALICKY J
WAND AJ
MOSER CC
Citation: Pl. Dutton et al., DESIGN OF REDOX SYSTEMS IN NATURE - SYNTHESIS OF REDOX PROTEINS IN THE LABORATORY, Biophysical journal, 74(2), 1998, pp. 117-117
Citation: N. Duval et al., COMBINATION OF ASPIRIN AND METOCLOPRAMIDE PRODUCES A SYNERGISTIC ANTITHROMBOTIC EFFECT IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS, Fundamental and clinical pharmacology, 11(1), 1997, pp. 57-62
Authors:
CAILLE D
BERGIS OE
FANKHAUSER C
GARDES A
ADAM R
CHARIERAS T
GROSSET A
ROVEI V
JARREAU FX
Citation: D. Caille et al., BEFLOXATONE, A NEW REVERSIBLE AND SELECTIVE MONOAMINE OXIDASE-A INHIBITOR .2. PHARMACOLOGICAL PROFILE, The Journal of pharmacology and experimental therapeutics, 277(1), 1996, pp. 265-277
Authors:
DUVAL N
LUNVEN C
OBRIEN DP
GROSSET A
OCONNOR SE
BERRY CN
Citation: N. Duval et al., ANTITHROMBOTIC ACTIONS OF THE THROMBIN INHIBITOR, ARGATROBAN, IN A CANINE MODEL OF CORONARY CYCLIC FLOW - COMPARISON WITH HEPARIN, British Journal of Pharmacology, 118(3), 1996, pp. 727-733
Authors:
LAROCHELLE CD
LAINEE P
GROSSET A
OCONNOR SE
Citation: Cd. Larochelle et al., CORONARY AND SYSTEMIC HEMODYNAMIC-EFFECTS OF THE PUTATIVE NITRIC-OXIDE DONOR, FK-409, IN COMPARISON WITH NITROGLYCERIN IN CONSCIOUS AND ANESTHETIZED DOGS, Journal of cardiovascular pharmacology, 26(4), 1995, pp. 555-563
Authors:
DUVAL N
LUNVEN C
GROSSET A
OBRIEN DP
BERRY CN
OCONNOR SE
Citation: N. Duval et al., EFFECTS OF ARGATROBAN, A SPECIFIC THROMBIN INHIBITOR, IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS, British Journal of Pharmacology, 114, 1995, pp. 200-200
Citation: Cd. Larochelle et al., COMPARISON OF THE HEMODYNAMIC PROFILES OF ELGODIPINE AND NICARDIPINE IN THE ANESTHETIZED DOG, British Journal of Pharmacology, 111(1), 1994, pp. 49-56
Authors:
ANGEL I
GROSSET A
PERRAULT G
SHOEMAKER H
LANGER SZ
Citation: I. Angel et al., INVIVO PHARMACOLOGICAL PROFILE OF SL-84.0418, A NEW SELECTIVE, PERIPHERALLY ACTIVE ALPHA-2-ADRENOCEPTOR ANTAGONIST, European journal of pharmacology, 234(2-3), 1993, pp. 137-145